Carbonic Anhydrase Inhibitor Eye Drops (Glaucoma)Generally Approved

Dorzolamide (Ophthalmic)

Brand names: Trusopt|Last verified: 2026-03-01

FAA Pathway: Standard issuance by AME; glaucoma evaluation required

Dorzolamide eye drops for glaucoma are generally acceptable for FAA certification. Topical carbonic anhydrase inhibitors have minimal systemic effects. Visual field evaluation is required for the underlying glaucoma.

Check your medications

Look up any medication in our FAA compatibility database.

Medication Checker

Related Resources

Pilot Tip

Always report all medications on your FAA medical application (Form 8500-8, Item 17a), even OTC medications. Failure to disclose is a far bigger issue than the medication itself.

Certification Details

Key Requirements

Visual field testing must meet FAA standards

Certificate Classes

All classes eligible if visual fields adequate

Notes

Topical use — minimal systemic absorption

Monitoring

Regular visual field and IOP testing

Sources

FAA AME Guide, Ophthalmology

Last verified: 2026-03-01

Frequently Asked Questions

Is Dorzolamide (Ophthalmic) allowed for pilots?

The FAA considers Dorzolamide (Ophthalmic) (Trusopt) to be "Generally Approved" for medical certification purposes. Dorzolamide eye drops for glaucoma are generally acceptable for FAA certification. Topical carbonic anhydrase inhibitors have minimal systemic effects. Visual field evaluation is required for the underlying glaucoma.

What is the FAA status of Dorzolamide (Ophthalmic)?

Dorzolamide (Ophthalmic) has a status of "Generally Approved" under FAA medical certification policy. The certification pathway is: Standard issuance by AME; glaucoma evaluation required.

Can I fly while taking Dorzolamide (Ophthalmic)?

Dorzolamide (Ophthalmic) is generally compatible with flying. However, you must report it on your FAA medical application (Form 8500-8) and ensure you are not experiencing side effects that could impair flight safety. Always consult your Aviation Medical Examiner (AME).

Important Notice

The FAA does not publish a comprehensive list of “approved” medications. The information on this page represents our interpretation of publicly available FAA guidance and is provided for informational and educational purposes only. It does not constitute medical advice, legal advice, or a guarantee of certification outcome.

The primary issue with the FAA is always whether the underlying medical condition — not just the medication — is compatible with safe flight. You should only start, stop, or change medications after consulting your treating physician. Always consult with a qualified Aviation Medical Examiner (AME) for guidance specific to your situation. FAA policies are subject to change. ClearedMed is not affiliated with or endorsed by the FAA.